AU1593797A - Use of fluvastatin derivatives in skin disease and topical compositions containing them - Google Patents

Use of fluvastatin derivatives in skin disease and topical compositions containing them

Info

Publication number
AU1593797A
AU1593797A AU15937/97A AU1593797A AU1593797A AU 1593797 A AU1593797 A AU 1593797A AU 15937/97 A AU15937/97 A AU 15937/97A AU 1593797 A AU1593797 A AU 1593797A AU 1593797 A AU1593797 A AU 1593797A
Authority
AU
Australia
Prior art keywords
fluvastatin
derivatives
compositions containing
skin disease
topical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15937/97A
Inventor
Katrin Kriwet
Neil Stewart Ryder
Andreas Werner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601294.3A external-priority patent/GB9601294D0/en
Priority claimed from GBGB9601297.6A external-priority patent/GB9601297D0/en
Priority claimed from GBGB9610225.6A external-priority patent/GB9610225D0/en
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU1593797A publication Critical patent/AU1593797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
AU15937/97A 1996-01-23 1997-01-21 Use of fluvastatin derivatives in skin disease and topical compositions containing them Abandoned AU1593797A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB9601297 1996-01-23
GBGB9601294.3A GB9601294D0 (en) 1996-01-23 1996-01-23 Organic compounds
GB9601294 1996-01-23
GBGB9601297.6A GB9601297D0 (en) 1996-01-23 1996-01-23 Organic compounds
GBGB9610225.6A GB9610225D0 (en) 1996-05-16 1996-05-16 Organic compounds
GB9610225 1996-05-16
PCT/EP1997/000270 WO1997026874A1 (en) 1996-01-23 1997-01-21 Use of fluvastatin derivatives in skin disease and topical compositions containing them

Publications (1)

Publication Number Publication Date
AU1593797A true AU1593797A (en) 1997-08-20

Family

ID=27268088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15937/97A Abandoned AU1593797A (en) 1996-01-23 1997-01-21 Use of fluvastatin derivatives in skin disease and topical compositions containing them

Country Status (3)

Country Link
AU (1) AU1593797A (en)
ID (1) ID15844A (en)
WO (1) WO1997026874A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801508B1 (en) * 1999-11-29 2003-11-14 Oreal USE OF HMG COA-REDUCTASE INHIBITORS FOR THE TREATMENT OF SEBORRHEA
US20020010128A1 (en) * 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
WO2004026297A1 (en) * 2002-09-20 2004-04-01 Kowa Co., Ltd. Preparation for external use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738510A3 (en) * 1995-04-20 2005-12-21 L'oreal Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties.

Also Published As

Publication number Publication date
WO1997026874A1 (en) 1997-07-31
ID15844A (en) 1997-08-14

Similar Documents

Publication Publication Date Title
AU3445697A (en) New use of xylitol and pharmaceutical compositions therefor
AU8905098A (en) Skin care compositions and use
HUP0003743A3 (en) Topical pharmaceutical composition containing resorcinol derivatives and its use for lightening skin or reducing the pigmentation of skin in a human
AU1926295A (en) Skin tanning compositions and methods for their preparation and use
AU4540697A (en) Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU3784193A (en) Reduction of swelling in hemorrhoidal tissues
AU2103097A (en) Cinnoline derivatives and use as medicine
PL327737A1 (en) Carbamoyloxylic derivatives of mutiline and their application as bactericides
AU2952997A (en) Thiocyano-triazolyl derivatives and their use as microbicides
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU2896597A (en) Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
EP0800815A3 (en) Use of at least one lypoxygenase inhibitor and at least one cyclo-oxygenase inhibitor to alter hair growth
AU1688495A (en) Reproduction and utilization of functional human tissue
AU2655097A (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
AU4964193A (en) Use of an ecdysteroid in cosmetics or dermatology
AU3352197A (en) Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials
AU4204697A (en) Tetrahydroisoquinoline derivatives and their pharmaceutical use
AU2036297A (en) Topical formulations of aciclovir
AU1990592A (en) Skin and hair-care gel compositions
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU6625698A (en) Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions
AU1593797A (en) Use of fluvastatin derivatives in skin disease and topical compositions containing them
AU2894997A (en) Mercapto-imidazolyl derivatives and their use as microbicides